9月26日港股通创新药ETF（159570）份额增加6100.00万份

Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (159570) experienced a decline of 1.60% with a trading volume of 2.74 billion yuan on September 26 [1] - The ETF's shares increased by 61 million, bringing the total shares to 11.366 billion, with a total increase of 1.574 billion shares over the past 20 trading days [1] - The latest net asset value of the ETF is calculated to be 21.339 billion yuan [1] Group 2 - The performance benchmark for the ETF is the National Index of Hong Kong Stock Connect Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by E Fund Management Co., Ltd., with the fund manager being Le Wuqiong [1] - Since its establishment on December 28, 2023, the ETF has achieved a return of 87.75%, while the return over the past month is -6.38% [1]